Cultured cell and transgenic mouse models for tau pathology linked to β-amyloid

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1739, Issue 2, 2005, Pages 116-124

  Bloom, George S ^a   Ren, Ke ^b   Glabe, Charles G ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b PURDUE PHARMA L P   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Apoptosis; Primary brain culture; Tauopathies

Indexed keywords

AMYLOID BETA PROTEIN; EPITOPE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL CULTURE; APOPTOSIS; BRAIN; BRAIN CELL; CONCENTRATION (PARAMETERS); GLIA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; MEDICAL LITERATURE; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PUBLICATION; REVIEW; SENSITIVITY ANALYSIS; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BRAIN; CELLS, CULTURED; HUMANS; MICE; MICE, TRANSGENIC; NEURONS; TAU PROTEINS; TAUOPATHIES;

MUS MUSCULUS;

EID: 10944244158     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.08.008     Document Type: Review

References (39)

1. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction Neuron 39 2003 409 421
2. J. Lewis, D.W. Dickson, W.-L. Lin, L. Chisholm, A. Corral, G. Jones, S.-H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP Science 293 2001 1487 1491
3. J. Götz, F. Chen, R. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils Science 293 2001 1491 1495
4. M.A. Kurt, D.C. Davies, M. Kidd, K. Duff, and D.R. Howlett Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes Neurobiol. Dis. 14 2003 89 97
5. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.H. Wiederhold, C. Mistl, S. Rothacher, B. Ledermann, K. Burki, P. Frey, P.A. Paganetti, C. Waridel, M.E. Calhoun, M. Jucker, A. Probst, M. Staufenbiel, and B. Sommer Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proc. Natl. Acad. Sci. U. S. A. 94 1997 13287 13292
6. M. Rapoport, H.N. Dawson, L.I. Binder, M.P. Vitek, and A. Ferreira Tau is essential to β-amyloid-induced neurotoxicity Proc. Natl. Acad. Sci. U. S. A. 99 2002 6364 6369
7. T. Liu, G. Perry, H.W. Chan, G. Verdile, R.N. Martins, M.A. Smith, and C.S. Atwood Amyloid-β-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression J. Neurochem. 88 2004 554 563
8. A. Ferrari, F. Hoerndli, T. Baechi, R.M. Nitsch, and J. Götz β-Amyloid induces PHF-like tau filaments in tissue culture J. Biol. Chem. 278 2003 40162 40168
9. J. Busciglio, A. Lorenzo, J. Yeh, and B.A. Yankner β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding Neuron 14 1995 879 888
10. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
11. R.E. Tanzi, D.M. Kovacs, T.W. Kim, R.D. Moir, S.Y. Guenette, and W. Wasco The gene defects responsible for familial Alzheimer's disease Neurobiol. Dis. 3 1996 159 168
12. V.M. Lee, M. Goedert, and J.Q. Trojanowski Neurodegenerative tauopathies Annu. Rev. Neurosci. 24 2001 1121 1159
13. A. Ferreira, Q. Lu, L. Orecchio, and K.S. Kosik Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar Aβ Mol. Cell. Neurosci. 9 1997 220 234
14. L. Lannfelt, N. Bogdanovic, H. Appelgren, K. Axelman, L. Lilius, G. Hansson, D. Schenk, J. Hardy, and B. Winblad Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family Neurosci. Lett. 168 1994 254 256
15. M. Mullan, F. Crawford, K. Axelman, H. Houlden, L. Lilius, B. Winblad, and L. Lannfelt A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid Nat. Genet. 1 1992 345 347
16. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
17. J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M.P. Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W.-L. Lin, S.-H. Yen, D.W. Dickson, P. Davies, and M. Hutton Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein Nat. Genet. 25 2000
18. J. Götz, F. Chen, R. Barmettler, and R.M. Nitsch Tau filament formation in transgenic mice expressing P301L tau J. Biol. Chem. 276 2001 529 534
19. G.S. Bloom, and R.B. Vallee Association of microtubule-associated protein 2 (MAP 2) with microtubules and intermediate filaments in cultured brain cells J. Cell Biol. 96 1983 1523 1531
20. D. Burdick, B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs J. Biol. Chem. 267 1992 546 554
21. P.A. Conrad, E.J. Smart, Y.-S. Ying, R.G.W. Anderson, and G.S. Bloom Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps J. Cell Biol. 131 1995 1421 1433
22. S.C. Papasozomenos, and L.I. Binder Phosphorylation determines two distinct species of tau in the central nervous system Cell Motil. Cytoskelet. 8 1987 210 226
23. L.I. Binder, A. Frankfurter, and L.I. Rebhun The distribution of tau in the nervous system J. Cell Biol. 101 1985 1371 1378
24. P. LoPresti, S. Szuchet, S.C. Papasozomenos, R.P. Zinkowski, and L.I. Binder Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes Proc. Natl. Acad. Sci. U. S. A. 92 1995 10369 10373
25. L.J. Otvos, L. Feiner, E. Lang, G.I. Szendrei, M. Goedert, and V.M.-Y. Lee Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404 J. Neurosci. Res. 39 1994 669 673
26. S.H. Blose, D.M. Meltzer, and J.R. Feramisco 10-nm filaments are induced to collapse in living cells microinjected with monoclonal and polyclonal antibodies against tubulin J. Cell Biol. 98 1984 847 858
27. F. Breitling, and M. Little Carboxy-terminal regions on the surface of tubulin and microtubules. Epitope locations of YOL1/34, DM1A and DM1B J. Mol. Biol. 189 1986 367 370
28. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
29. T. Pillot, B. Drouet, S. Queille, C. Labeur, J. Vandekerchkhove, M. Rosseneu, M. Pinçon-Raymond, and J. Chambaz The nonfibrillar amyloid β-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain J. Neurochem. 73 1999 1626 1634
30. G.S. Bloom, T.A. Schoenfeld, and R.B. Vallee Widespread distribution of the major polypeptide component of MAP1 (microtubule-associated protein 1) in the nervous system J. Cell Biol. 98 1984 320 330
31. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
32. B.L. Trigatti, R.G.W. Anderson, and G.E. Gerber Caveolin binds long chain unsaturated fatty acids with high affinity J. Biol. Chem. 1995 (submitted for publication)
33. J.C. Cruz, H.C. Tseng, J.A. Goldman, H. Shih, and L.H. Tsai Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles Neuron 40 2003 471 483
34. W. Noble, V. Olm, K. Takata, E. Casey, O. Mary, J. Meyerson, K. Gaynor, J. LaFrancois, L. Wang, T. Kondo, P. Davies, M. Burns, Veeranna, R. Nixon, D. Dickson, Y. Matsuoka, M. Ahlijanian, L.F. Lau, and K. Duff Cdk5 is a key factor in tau aggregation and tangle formation in vivo Neuron 38 2003 555 565
35. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, A.L. Guillozet, M. Lu, Y. Fu, F. Garcia-Sierra, N. LaPointe, R. Miller, R.W. Berry, L.I. Binder, and V.L. Cryns Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 100 2003 10032 10037
36. Y. Zhang, R. McLaughlin, C. Goodyer, and A. LeBlanc Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons J. Cell Biol. 156 2002 519 529
37. K.B. Rank, A.M. Pauley, K. Bhattacharya, Z. Wang, D.B. Evans, T.J. Fleck, J.A. Johnston, and S.K. Sharma Direct interaction of soluble human recombinant tau protein with Aβ 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II FEBS Lett. 514 2002 263 268
38. G.R. Jackson, M. Wiedau-Pazos, T.K. Sang, N. Wagle, C.A. Brown, S. Massachi, and D.H. Geschwind Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila Neuron 34 2002 509 519
39. mark) J. Biol. Chem. 270 1995 7679 7688